Trials (Nov 2020)

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

  • Christina M. Eckhardt,
  • Matthew J. Cummings,
  • Kartik N. Rajagopalan,
  • Sarah Borden,
  • Zachary C. Bitan,
  • Allison Wolf,
  • Alex Kantor,
  • Thomas Briese,
  • Benjamin J. Meyer,
  • Samuel D. Jacobson,
  • Dawn Scotto,
  • Nischay Mishra,
  • Neena M. Philip,
  • Brie A. Stotler,
  • Joseph Schwartz,
  • Beth Shaz,
  • Steven L. Spitalnik,
  • Andrew Eisenberger,
  • Eldad A. Hod Jessica Justman,
  • Ken Cheung,
  • W. Ian Lipkin,
  • Max R. O’Donnell

DOI
https://doi.org/10.1186/s13063-020-04877-z
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 2

Abstract

Read online

An amendment to this paper has been published and can be accessed via the original article.